The George Institute for Global Health is thrilled to congratulate doctoral researcher Dr Lauren Heath on receiving a ...
With almost half of American adults living with high blood pressure, it makes sense that you'd want every possible tool in ...
Shrugging off an earlier phase 3 disappointment, Travere’s Filspari has become the first FDA-approved treatment for rare ...
Scientists have now developed a new drug called baxdrostat, which offers hope by lowering blood pressure in these tough cases ...
In a recent study of older patients with end-stage kidney disease living in Europe, researchers found o ne-third received an ...
A new pill called baxdrostat is showing strong results in lowering dangerously high blood pressure in people who don’t ...
MedPage Today on MSN
FDA Approves Sparsentan as First FSGS Treatment
Expanded indication supported by mixed bag of trial data ...
Climb Bio, Inc. stays a Buy on budoprutug pMN data; Phase 2 PrisMN readout 2H 2026 + SLE/ITP upside and 2028 cash runway.
VESALIUS-CV data supported evolocumab reducing MACE in high-risk primary prevention diabetes over 4.8 years, reinforcing the ...
Watchdog publishes protocol for a health technology assessment of the addition of congenital adrenal hyperplasia to the ‘heel prick’ test ...
One drink was the clear winner. Here’s why you should start your day with it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results